Wutah dodolan YoY sajrone rolas wulan kepungkur: NewAmsterdam Pharma Corp (NAMS)

Logo grafis NewAmsterdam Pharma (NAMS)

NewAmsterdam Pharma (NAMS) is strengthening its market position through patents for a unique cholesterol drug, confirming the brand's high scientific reputation among cardiologists. The trailing 12-month sales performance relative to the previous year demonstrates a growth trajectory where the metric reached the level of -26.90. Simultaneously, the company is implementing digital patient monitoring, reducing transport emissions and the environmental footprint of its research.

Wutah dodolan YoY sajrone rolas wulan kepungkur: NewAmsterdam Pharma N.V. (NAMS) kanggo 11.02.2024 - 18.11.2026

Ringkesan rincian data analitis NewAmsterdam Pharma N.V. (NAMS)

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:NewAmsterdam Pharma
Produk seri NewAmsterdam Pharma Company

The development of unique oral CETP inhibitors for statin-intolerant patients creates potential for significant pricing power for NewAmsterdam Pharma (NAMS). This expansion trend is reflected in the TTM annual revenue growth rate, which captures the market consensus regarding the business's operational strength. This metric measures the cash change in sales volume over the last twelve months based on daily updates. The steady growth of this indicator confirms the company's fundamental resilience and commercial success.

Analisis pesaing NewAmsterdam Pharma

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|AKRO - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Metsera Therapeutics|MoonLake Corp (MLTX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur crinetics.com (CRNX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur soleno.life SLNO|Wutah dodolan YoY (TTM) FOLD (amicusrx.com)|Wutah pendapatan taunan sajrone rolas wulan kepungkur 89bio (ETNB)|Agios - Wutah dodolan YoY (TTM)|Structure Corp - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|mimedx.com (MDXG) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan taun lumaku RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur MBX|Wutah dodolan YoY sajrone rolas wulan kepungkur Altimmune Pharma (ALT)|Wutah dodolan YoY sajrone rolas wulan kepungkur AARD (Aardvark Therapeutics Corp)|Wutah dodolan YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Wutah pendapatan taun lumaku|BMEA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|vTv Therapeutics, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Agape ATP Corp.|Wutah pendapatan YoY sajrone 12 wulan kepungkur Pluri (PLUR)|Wutah dodolan YoY (TTM) SYBX|Wutah pendapatan taunan sajrone rolas wulan kepungkur Lipocine Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur Matinas BioPharma Holdings MTNB|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)